CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 80 enrolled
Drug / intervention
Ankaferd Blood Stopper in theTraumatic Bleedingprocedure
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT03871452
NCT03871452N/ACompleted

Haydarpaşa Numune Education and Research Hospital

Haydarpasa Numune Training and Research Hospital·interventional·Posted Mar 12, 2019·Updated Mar 12, 2019

In Brief

A clinical study evaluating Ankaferd Blood Stopper in theTraumatic Bleeding for Bleeding Disorder. Completed, enrolled 80 participants across 1 site.

Detailed Summary

The objective of this study was to prospectively compare effectiveness of Ankaferd Blood Stopper (ABS) with dry sponges in cessation of bleeding in adult trauma cases with external bleeding due to extremity lacerations. Methods: The study was conducted on patients with bleeding associated with extremity lacerations. All consecutive patients presented to the emergency department of the high-volume training hospital in Istanbul were recruited within the study period

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
CountriesTurkey (Türkiye)
Collaborators--

Timeline

N/ACompletedFinished
20192020202120222023202420252026
First PostedMar 12, 2019
Enrollment StartOct 1, 2018
Primary CompletionOct 11, 2018
Study CompletionOct 23, 2018
TodayJul 2, 2026
Enrollment to primary: 10 daysPosted 7.3 years ago

Interventions

Ankaferd Blood Stopper in theTraumatic Bleedingprocedure

ankaferd blood stpper They were trained to apply compression of approximately 3-kg weight after irrigation with saline in patients with active bleeding who met inclusion criteria. Bleeding was controlled in every minute and data were collected. Traditional methods such as primary suturing were performed in patients whose bleeding did not stop within 10 minutes. Patients whose bleeding was stopped were monitored for half an hour for bleeding recurrence. The patients were divided into two groups; ones treated by ABS soaked wet compresses (group I) and ones treated by dry sponge compresses